Clearmind Medicine Statistics Share Statistics Clearmind Medicine has 5.46M
shares outstanding. The number of shares has increased by 32.62%
in one year.
Shares Outstanding 5.46M Shares Change (YoY) 32.62% Shares Change (QoQ) 4.76% Owned by Institutions (%) n/a Shares Floating 5.32M Failed to Deliver (FTD) Shares 3,052 FTD / Avg. Volume 0.21%
Short Selling Information The latest short interest is 71.56K, so 1.31% of the outstanding
shares have been sold short.
Short Interest 71.56K Short % of Shares Out 1.31% Short % of Float 1.35% Short Ratio (days to cover) 2.19
Valuation Ratios The PE ratio is -1.13 and the forward
PE ratio is null.
Clearmind Medicine's PEG ratio is
0.01.
PE Ratio -1.13 Forward PE n/a PS Ratio 0 Forward PS n/a PB Ratio 1.91 P/FCF Ratio -1.22 PEG Ratio 0.01
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Clearmind Medicine.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 1.72,
with a Debt / Equity ratio of 0.02.
Current Ratio 1.72 Quick Ratio 1.72 Debt / Equity 0.02 Debt / EBITDA -0.01 Debt / FCF -0.01 Interest Coverage -221.21
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-1.31M Employee Count 4 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax 377.97K Effective Tax Rate -7.75%
Stock Price Statistics The stock price has increased by -16% in the
last 52 weeks. The beta is -1.24, so Clearmind Medicine's
price volatility has been lower than the market average.
Beta -1.24 52-Week Price Change -16% 50-Day Moving Average 1.03 200-Day Moving Average 1.11 Relative Strength Index (RSI) 51.55 Average Volume (20 Days) 1,440,711
Income Statement
Revenue n/a Gross Profit -26.7K Operating Income -8M Net Income -5.25M EBITDA -7.98M EBIT -8M Earnings Per Share (EPS) -1.69
Full Income Statement Balance Sheet The company has 6.57M in cash and 53.14K in
debt, giving a net cash position of 6.52M.
Cash & Cash Equivalents 6.57M Total Debt 53.14K Net Cash 6.52M Retained Earnings -24.02M Total Assets 5.18M Working Capital 2.14M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -4.86M
and capital expenditures 0, giving a free cash flow of -4.86M.
Operating Cash Flow -4.86M Capital Expenditures n/a Free Cash Flow -4.86M FCF Per Share -1.14
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
Dividends & Yields CMND does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast Currently there are no analyst rating for CMND.
Price Target n/a Price Target Difference n/a Analyst Consensus n/a Analyst Count n/a
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Nov 28, 2023. It was a
backward
split with a ratio of 1:30.
Last Split Date Nov 28, 2023 Split Type backward Split Ratio 1:30
Scores Altman Z-Score -8.5 Piotroski F-Score 1
